MSTN and sarcopenia: This study aimed to examine the association of biomarkers recommended by the ESCEO guidelines—including adiponectin, myostatin, P3NP, CRP and TNF‐α—with sarcopenia diagnostic criteria using plasma‐derived EV markers in a prospective cohort.